Status:
COMPLETED
A Phase 3 Study of OPC-262 in Patients With Type 2 Diabetes
Lead Sponsor:
Kyowa Kirin Co., Ltd.
Conditions:
Diabetes, Type 2
Eligibility:
All Genders
20+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to investigate the safety of OPC-262 administered orally in combination with another oral antihyperglycemic agent
Eligibility Criteria
Inclusion
- 1\) Patients who are capable of giving informed consent
- 2\) Patients who are able to take contraceptive measures to avoid pregnancy of the patient or the patient's partner
Exclusion
- Patients with severe ketosis, diabetic coma or precoma, or type 1 diabetes mellitus
Key Trial Info
Start Date :
July 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2012
Estimated Enrollment :
450 Patients enrolled
Trial Details
Trial ID
NCT01193179
Start Date
July 1 2010
End Date
April 1 2012
Last Update
January 8 2014
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Kanto Rigeon, Japan
2
Kinki Region, Japan
3
Kyushu Region, Japan
4
Tohoku Region, Japan